• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种小分子稳定了阿尔茨海默氏症 Aβ肽的无规则天然状态。

A Small Molecule Stabilizes the Disordered Native State of the Alzheimer's Aβ Peptide.

机构信息

Department of Chemistry, University of Cambridge, CB2 1EW Cambridge, UK.

Google Research, Mountain View, California 94043, United States.

出版信息

ACS Chem Neurosci. 2022 Jun 15;13(12):1738-1745. doi: 10.1021/acschemneuro.2c00116. Epub 2022 Jun 1.

DOI:10.1021/acschemneuro.2c00116
PMID:35649268
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9204762/
Abstract

The stabilization of native states of proteins is a powerful drug discovery strategy. It is still unclear, however, whether this approach can be applied to intrinsically disordered proteins. Here, we report a small molecule that stabilizes the native state of the Aβ42 peptide, an intrinsically disordered protein fragment associated with Alzheimer's disease. We show that this stabilization takes place by a disordered binding mechanism, in which both the small molecule and the Aβ42 peptide remain disordered. This disordered binding mechanism involves enthalpically favorable local π-stacking interactions coupled with entropically advantageous global effects. These results indicate that small molecules can stabilize disordered proteins in their native states through transient non-specific interactions that provide enthalpic gain while simultaneously increasing the conformational entropy of the proteins.

摘要

稳定蛋白质的天然状态是一种强有力的药物发现策略。然而,目前尚不清楚这种方法是否可以应用于天然无序蛋白质。在这里,我们报告了一种小分子,可以稳定与阿尔茨海默病相关的 Aβ42 肽这种天然无序蛋白质片段的天然状态。我们表明,这种稳定化是通过无规结合机制发生的,其中小分子和 Aβ42 肽都保持无规状态。这种无规结合机制涉及有利的局部π-堆积相互作用与有利的全局熵效应相结合。这些结果表明,小分子可以通过提供焓增益的瞬时非特异性相互作用来稳定天然状态下的无序蛋白质,同时增加蛋白质的构象熵。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d39/9204762/63d503d3c322/cn2c00116_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d39/9204762/db53d49322db/cn2c00116_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d39/9204762/f0dc7ad9a7ae/cn2c00116_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d39/9204762/2319e75b69ee/cn2c00116_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d39/9204762/63d503d3c322/cn2c00116_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d39/9204762/db53d49322db/cn2c00116_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d39/9204762/f0dc7ad9a7ae/cn2c00116_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d39/9204762/2319e75b69ee/cn2c00116_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d39/9204762/63d503d3c322/cn2c00116_0005.jpg

相似文献

1
A Small Molecule Stabilizes the Disordered Native State of the Alzheimer's Aβ Peptide.一种小分子稳定了阿尔茨海默氏症 Aβ肽的无规则天然状态。
ACS Chem Neurosci. 2022 Jun 15;13(12):1738-1745. doi: 10.1021/acschemneuro.2c00116. Epub 2022 Jun 1.
2
Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease.小分子结合淀粉样蛋白-β作为阿尔茨海默病的药物发现策略。
Sci Adv. 2020 Nov 4;6(45). doi: 10.1126/sciadv.abb5924. Print 2020 Nov.
3
A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins.一种基于片段的小分子文库构建方法,用于靶向内在无序蛋白质的聚集。
ACS Comb Sci. 2016 Mar 14;18(3):144-53. doi: 10.1021/acscombsci.5b00129. Epub 2016 Feb 29.
4
Beta Amyloid Hallmarks: From Intrinsically Disordered Proteins to Alzheimer's Disease.β淀粉样蛋白特征:从内在无序蛋白质到阿尔茨海默病
Adv Exp Med Biol. 2015;870:401-21. doi: 10.1007/978-3-319-20164-1_14.
5
Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer's Disease?1.p3 肽(Aβ17-40、Aβ17-42)与阿尔茨海默病的病理学有关吗?1.
J Alzheimers Dis. 2020;74(1):43-53. doi: 10.3233/JAD-191201.
6
Differences in the free energies between the excited states of A40 and A42 monomers encode their aggregation propensities.A40 和 A42 单体激发态之间的自由能差异编码了它们的聚集倾向。
Proc Natl Acad Sci U S A. 2020 Aug 18;117(33):19926-19937. doi: 10.1073/pnas.2002570117. Epub 2020 Jul 30.
7
The dark side of Alzheimer's disease: unstructured biology of proteins from the amyloid cascade signaling pathway.阿尔茨海默病的阴暗面:淀粉样蛋白级联信号通路中蛋白质的非结构化生物学。
Cell Mol Life Sci. 2020 Oct;77(20):4163-4208. doi: 10.1007/s00018-019-03414-9. Epub 2020 Jan 2.
8
Modeling structural interconversion in Alzheimers' amyloid beta peptide with classical and intrinsically disordered protein force fields.利用经典和内在无序蛋白质力场对阿尔茨海默病淀粉样β肽中的结构相互转化进行建模。
J Biomol Struct Dyn. 2022;40(20):10005-10022. doi: 10.1080/07391102.2021.1939163. Epub 2021 Jun 21.
9
N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.丹参酮或其类似物在抑制淀粉样蛋白聚集和已形成淀粉样纤维解聚方面的N端结合偏好——迈向引入一种新型抗阿尔茨海默病化合物
ACS Chem Neurosci. 2017 Jul 19;8(7):1577-1588. doi: 10.1021/acschemneuro.7b00080. Epub 2017 Apr 28.
10
PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.PTI-125 降低阿尔茨海默病患者的生物标志物。
J Prev Alzheimers Dis. 2020;7(4):256-264. doi: 10.14283/jpad.2020.6.

引用本文的文献

1
Ensemble Docking for Intrinsically Disordered Proteins.内在无序蛋白质的集成对接
J Chem Inf Model. 2025 Jul 14;65(13):6847-6860. doi: 10.1021/acs.jcim.5c00370. Epub 2025 Jun 18.
2
Covalent Adducts Formed by the Androgen Receptor Transactivation Domain and Small Molecule Drugs Remain Disordered.雄激素受体反式激活结构域与小分子药物形成的共价加合物仍处于无序状态。
J Chem Inf Model. 2025 May 30. doi: 10.1021/acs.jcim.5c00833.
3
Evidence of α-Synuclein/Glucocerebrosidase Dual Targeting by Iminosugar Derivatives.亚氨基糖衍生物对α-突触核蛋白/葡萄糖脑苷脂酶的双重靶向作用的证据

本文引用的文献

1
A kinetic ensemble of the Alzheimer's Aβ peptide.阿尔茨海默病Aβ肽的动力学集合体。
Nat Comput Sci. 2021 Jan;1(1):71-78. doi: 10.1038/s43588-020-00003-w. Epub 2021 Jan 14.
2
Molecular Basis of Small-Molecule Binding to α-Synuclein.小分子与α-突触核蛋白结合的分子基础。
J Am Chem Soc. 2022 Feb 16;144(6):2501-2510. doi: 10.1021/jacs.1c07591. Epub 2022 Feb 7.
3
Progress in deep Markov state modeling: Coarse graining and experimental data restraints.深度马尔可夫态模型研究进展:粗粒化和实验数据约束。
ACS Chem Neurosci. 2025 Apr 2;16(7):1251-1257. doi: 10.1021/acschemneuro.4c00618. Epub 2025 Mar 13.
4
Atomistic molecular dynamics simulations of intrinsically disordered proteins.内在无序蛋白质的原子分子动力学模拟
Curr Opin Struct Biol. 2025 Jun;92:103029. doi: 10.1016/j.sbi.2025.103029. Epub 2025 Mar 10.
5
Ensemble docking for intrinsically disordered proteins.内在无序蛋白质的集成对接
bioRxiv. 2025 Jan 26:2025.01.23.634614. doi: 10.1101/2025.01.23.634614.
6
An integrated machine learning approach delineates an entropic expansion mechanism for the binding of a small molecule to α-synuclein.一种集成机器学习方法描绘了小分子与α-突触核蛋白结合的熵扩展机制。
Elife. 2024 Dec 18;13:RP97709. doi: 10.7554/eLife.97709.
7
Covalent adducts formed by the androgen receptor transactivation domain and small molecule drugs remain disordered.雄激素受体反式激活结构域与小分子药物形成的共价加合物仍处于无序状态。
bioRxiv. 2024 Nov 15:2024.11.12.623257. doi: 10.1101/2024.11.12.623257.
8
Nitroxyl Hybrids with Curcumin and Stilbene Scaffolds Display Potent Antioxidant Activity, Remodel the Amyloid Beta Oligomer, and Reverse Amyloid Beta-Induced Cytotoxicity.具有姜黄素和芪支架的硝酰基杂化物具有强大的抗氧化活性,重塑淀粉样β寡聚体,并逆转淀粉样β诱导的细胞毒性。
Antioxidants (Basel). 2024 Nov 18;13(11):1411. doi: 10.3390/antiox13111411.
9
N-terminal domain of androgen receptor is a major therapeutic barrier and potential pharmacological target for treating castration resistant prostate cancer: a comprehensive review.雄激素受体的N端结构域是治疗去势抵抗性前列腺癌的主要治疗障碍和潜在药理学靶点:一篇综述
Front Pharmacol. 2024 Sep 18;15:1451957. doi: 10.3389/fphar.2024.1451957. eCollection 2024.
10
AlzDiscovery: A computational tool to identify Alzheimer's disease-causing missense mutations using protein structure information.AlzDiscovery:一种利用蛋白质结构信息识别阿尔茨海默病致病错义突变的计算工具。
Protein Sci. 2024 Oct;33(10):e5147. doi: 10.1002/pro.5147.
J Chem Phys. 2021 Dec 7;155(21):214106. doi: 10.1063/5.0064668.
4
The Amyloid-β Pathway in Alzheimer's Disease.阿尔茨海默病中的淀粉样β 途径。
Mol Psychiatry. 2021 Oct;26(10):5481-5503. doi: 10.1038/s41380-021-01249-0. Epub 2021 Aug 30.
5
Alzheimer's disease drug development pipeline: 2021.2021年阿尔茨海默病药物研发进展
Alzheimers Dement (N Y). 2021 May 25;7(1):e12179. doi: 10.1002/trc2.12179. eCollection 2021.
6
Thermodynamics and kinetics of the amyloid-β peptide revealed by Markov state models based on MD data in agreement with experiment.基于分子动力学(MD)数据的马尔可夫状态模型揭示的β-淀粉样肽的热力学和动力学与实验结果一致。
Chem Sci. 2021 Apr 15;12(19):6652-6669. doi: 10.1039/d0sc04657d.
7
What Markov State Models Can and Cannot Do: Correlation versus Path-Based Observables in Protein-Folding Models.马尔可夫状态模型能做什么与不能做什么:蛋白质折叠模型中基于相关性与基于路径的可观测量
J Chem Theory Comput. 2021 May 11;17(5):3119-3133. doi: 10.1021/acs.jctc.0c01154. Epub 2021 Apr 27.
8
Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story.罕见病药物研发:以塔法米迪司为例
Drug Des Devel Ther. 2021 Mar 18;15:1225-1243. doi: 10.2147/DDDT.S289772. eCollection 2021.
9
Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers.抑制剂结合后淀粉样蛋白-β的结构重排抑制了阿尔茨海默病相关寡聚物的形成。
Elife. 2020 Oct 23;9:e59306. doi: 10.7554/eLife.59306.
10
Mechanism of Coupled Folding-upon-Binding of an Intrinsically Disordered Protein.结合态下无序蛋白的折叠机制。
J Am Chem Soc. 2020 Jun 24;142(25):11092-11101. doi: 10.1021/jacs.0c03217. Epub 2020 Jun 16.